- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-824X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Nanotechnology-mediated targeting of tumor angiogenesis ; volume:3 ; number:1 ; day:31 ; month:1 ; year:2011 ; pages:1-13 ; date:12.2011
Vascular cell ; 3, Heft 1 (31.1.2011), 1-13, 12.2011
- Urheber
-
Banerjee, Deboshri
Harfouche, Rania
Sengupta, Shiladitya
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/2045-824X-3-3
- URN
-
urn:nbn:de:101:1-2021081519493385499440
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Banerjee, Deboshri
- Harfouche, Rania
- Sengupta, Shiladitya
- SpringerLink (Online service)
Ähnliche Objekte (12)
Recent advances of nanotechnology-based tumor vessel-targeting strategies
Receptor-mediated tumor targeting based on peptide hormones
Targeting angiogenesis in Duchenne muscular dystrophy
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation
Nanotechnology
Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis
New molecular mediators in tumor angiogenesis
A promising anti-tumor targeting on ERMMDs mediated abnormal lipid metabolism in tumor cells
Recent advances of nanotechnology-based tumor vessel-targeting strategies
Receptor-mediated tumor targeting based on peptide hormones
Targeting angiogenesis in Duchenne muscular dystrophy
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation
Nanotechnology
Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis
New molecular mediators in tumor angiogenesis
A promising anti-tumor targeting on ERMMDs mediated abnormal lipid metabolism in tumor cells
Recent advances of nanotechnology-based tumor vessel-targeting strategies
Receptor-mediated tumor targeting based on peptide hormones
Targeting angiogenesis in Duchenne muscular dystrophy
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
Targeting mitochondria by mitochondrial fusion, mitochondria-specific peptides and nanotechnology
A novel c-Met/TRK inhibitor 1D228 efficiently inhibits tumor growth by targeting angiogenesis and tumor cell proliferation
Nanotechnology
Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis
New molecular mediators in tumor angiogenesis